Choksi Laboratories Limited (BOM:526546)
134.55
+2.30 (1.74%)
At close: Aug 21, 2026
Choksi Laboratories Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 937 | 722 | 837 | 295 | 233 | 177 | |
Market Cap Growth | -40.11% | -13.78% | 183.51% | 26.73% | 31.65% | 221.93% |
Enterprise Value | 1,277 | 1,013 | 1,135 | 612 | 598 | 548 |
Last Close Price | 134.55 | 103.60 | 120.15 | 42.38 | 33.44 | 25.40 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 43.25 | 36.73 | 54.94 | 26.60 | 7.26 | 85.47 |
PS Ratio | 2.00 | 1.57 | 2.00 | 0.80 | 0.68 | 0.59 |
PB Ratio | 3.66 | 2.82 | 3.55 | 1.33 | 1.10 | 0.99 |
P/TBV Ratio | 3.72 | 2.87 | 3.62 | 1.35 | 1.12 | 1.01 |
P/FCF Ratio | - | - | 19.29 | 6.49 | 5.42 | 3.40 |
P/OCF Ratio | 11.92 | 9.18 | 7.11 | 2.56 | 2.82 | 2.25 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 2.73 | 2.20 | 2.72 | 1.67 | 1.74 | 1.83 |
EV/EBITDA Ratio | 10.20 | 8.35 | 10.63 | 5.99 | 5.84 | 6.16 |
EV/EBIT Ratio | 24.86 | 20.07 | 23.90 | 13.56 | 12.60 | 15.81 |
EV/FCF Ratio | - | - | 26.15 | 13.46 | 13.90 | 10.55 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 1.34 | 1.34 | 1.24 | 1.39 | 1.54 | 2.08 |
Debt / EBITDA Ratio | 2.73 | 2.82 | 2.62 | 3.02 | 3.17 | 4.19 |
Debt / FCF Ratio | - | - | 6.72 | 6.79 | 7.54 | 7.17 |
Net Debt / Equity Ratio | 1.33 | 1.33 | 1.21 | 1.36 | 1.51 | 2.06 |
Net Debt / EBITDA Ratio | 2.71 | 2.80 | 2.68 | 2.95 | 3.11 | 4.15 |
Net Debt / FCF Ratio | - | -301.63 | 6.58 | 6.64 | 7.40 | 7.10 |
Asset Turnover | - | 0.67 | 0.66 | 0.60 | 0.55 | 0.46 |
Inventory Turnover | - | 69.25 | 43.60 | 59.75 | 67.89 | 77.22 |
Quick Ratio | - | 0.76 | 0.56 | 0.59 | 0.94 | 0.78 |
Current Ratio | - | 0.82 | 0.68 | 0.77 | 1.11 | 0.90 |
Return on Equity (ROE) | - | 7.99% | 6.65% | 5.12% | 16.46% | 1.16% |
Return on Assets (ROA) | - | 4.60% | 4.66% | 4.61% | 4.75% | 3.31% |
Return on Invested Capital (ROIC) | 5.89% | 5.56% | 6.42% | 5.72% | 7.60% | 3.51% |
Return on Capital Employed (ROCE) | - | 10.30% | 11.50% | 10.50% | 9.90% | 7.10% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 2.31% | 2.72% | 1.82% | 3.76% | 13.78% | 1.17% |
FCF Yield | -0.12% | -0.16% | 5.18% | 15.40% | 18.47% | 29.38% |
Buyback Yield / Dilution | 0.06% | -0.01% | - | - | - | - |